News

An international study led by MHH compares genomic data from national biobanks worldwide and identifies new risk factors in ...
Immunotherapy, a breakthrough treatment for many cancers, has failed in ovarian cancer, largely because activity of surrounding cells has been programmed by the tumor to suppress the immune response.
A team led by UT Southwestern Medical Center researchers has uncovered the atomic structure of a protein complex pivotal to the function of motile cilia, the hair-like structures extending from ...
Researchers from Japan and France have successfully reconstituted the development of mouse egg cells, known as oocytes, from embryonic stem cells entirely in vitro, without the need for ovarian ...
Scientists create smart cells that administer automatic treatments from inside the human body, reacting within seconds to disease markers.
Based on these challenges, there is a pressing need to develop targeted, AI-driven stem cell therapies to restore ovarian function.
Tumor-restricted activation of Vγ9Vδ2 T cells via bispecific Evobodies: a novel strategy for safe and potent immunotherapy in ovarian cancer ...
Spatiotemporal regulation of ventilator lung injury resolution by TGF-β1+ regulatory B cells via macrophage vesicle-nanotherapeutics ...